BlackRock’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01M | Sell |
381,125
-18,841
| -5% | -$248K | ﹤0.01% | 3711 |
|
|
2025
Q1 | $5.75M | Sell |
399,966
-100,958
| -20% | -$1.45M | ﹤0.01% | 3550 |
|
|
2024
Q4 | $8.39M | Sell |
500,924
-58,796
| -11% | -$985K | ﹤0.01% | 3469 |
|
|
2024
Q3 | $8.95M | Buy |
559,720
+95,098
| +20% | +$1.52M | ﹤0.01% | 3421 |
|
|
2024
Q2 | $4.2M | Buy |
464,622
+82,160
| +21% | +$742K | ﹤0.01% | 3699 |
|
|
2024
Q1 | $4.32M | Buy |
382,462
+36,191
| +10% | +$409K | ﹤0.01% | 3674 |
|
|
2023
Q4 | $2.76M | Buy |
346,271
+20,428
| +6% | +$163K | ﹤0.01% | 3845 |
|
|
2023
Q3 | $2.11M | Buy |
325,843
+31,343
| +11% | +$203K | ﹤0.01% | 3912 |
|
|
2023
Q2 | $1.82M | Buy |
294,500
+1,840
| +0.6% | +$11.4K | ﹤0.01% | 4004 |
|
|
2023
Q1 | $1.13M | Sell |
292,660
-17,381
| -6% | -$66.9K | ﹤0.01% | 4217 |
|
|
2022
Q4 | $961K | Buy |
310,041
+16,530
| +6% | +$51.2K | ﹤0.01% | 4342 |
|
|
2022
Q3 | $1.18M | Sell |
293,511
-8,404
| -3% | -$33.8K | ﹤0.01% | 4332 |
|
|
2022
Q2 | $1.47M | Buy |
301,915
+25,397
| +9% | +$124K | ﹤0.01% | 4291 |
|
|
2022
Q1 | $2.48M | Sell |
276,518
-10,720
| -4% | -$96.2K | ﹤0.01% | 4217 |
|
|
2021
Q4 | $3.23M | Buy |
+287,238
| New | +$3.23M | ﹤0.01% | 4128 |
|
|
2021
Q3 | – | Sell |
-4,992
| Closed | -$110K | – | 5547 |
|
|
2021
Q2 | $110K | Buy |
+4,992
| New | +$110K | ﹤0.01% | 4951 |
|